Your shopping cart is currently empty

Resomelagonmethanesulfonate (AP1189 methanesulfonate) is the methanesulfonate salt form of Resomelagon. It is an orally active melanocortin receptor (MR) agonist that induces ERK1/2 phosphorylation and Ca2+ mobilization. In mouse models of peritonitis and arthritis, Resomelagonmethanesulfonate demonstrates anti-inflammatory activity and can be used for research on obesity and chronic inflammation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | Resomelagonmethanesulfonate (AP1189 methanesulfonate) is the methanesulfonate salt form of Resomelagon. It is an orally active melanocortin receptor (MR) agonist that induces ERK1/2 phosphorylation and Ca2+ mobilization. In mouse models of peritonitis and arthritis, Resomelagonmethanesulfonate demonstrates anti-inflammatory activity and can be used for research on obesity and chronic inflammation. |
| Synonyms | AP1189 methanesulfonate |
| Molecular Weight | 394.41 |
| Formula | C15H18N6O5S |
| Cas No. | 2933183-20-9 |
| Smiles | S(C)(=O)(=O)O.C(=C/C=N/NC(=N)N)\C=1N(C=CC1)C2=C(N(=O)=O)C=CC=C2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.